查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球神經血管導管市場
市場調查報告書
商品編碼
1140765

2022-2029 年全球神經血管導管市場

Global Neurovascular Catheters Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

預計神經血管導管的市場規模在預測期間（2022-2029 年）將以 6.7% 的複合年增長率增長。

神經血管導管用於從神經血管器官（例如大腦、顱腔和頸動脈）排出或抽取不需要的液體。我們還向神經血管器官給藥並診斷神經血管疾病，例如動脈瘤和頸動脈疾病。

市場動態

由於神經血管疾病的流行、研發投資和技術進步，全球神經血管導管市場正在增長。

神經血管疾病的日益流行和技術進步正在推動全球市場的增長。

缺血性中風、狹窄和腦動脈瘤等神經血管疾病病例不斷增加，預計將推動市場增長。例如，根據世界衛生組織的數據，三分之一的人會在他們生命的某個階段患上神經系統疾病。過去 30 年來，神經系統疾病導致的死亡人數增加了近 40%。根據世界中風組織 (WSO) 的數據，中風仍然是導致死亡的第二大原因，也是導致死亡和殘疾的第三大原因。在全球範圍內，70% 的中風和 87% 的中風相關死亡和殘疾調整生命年發生在低收入和中等收入國家。全世界每年約有 1500 萬人中風。其中，500 萬人死亡，另外 500 萬人永久殘疾。因此，越來越多的缺血性中風患者正在推動市場。

並發症和熟練專業人員的短缺正在阻礙全球神經血管導管市場的增長。

與神經血管導管相關的並發症預計將抑制市場。在血管中放置導管的過程存在一定的風險。這些包括受損的血管、穿刺部位出血和感染。 FDA 表示，它已收到少量不良事件報告，表明患者受傷和至少一名死亡與以這種方式使用的神經血管引導導管有關。此外，在血栓切除術中使用神經血管引導導管對安全性和性能有影響，並且在微血管最遠端區域使用時會產生嚴重的並發症，如裝置故障和穿孔、血管損傷和夾層等，可能會產生嚴重的副作用。

行業分析

《全球神經血管導管市場報告》根據波特五力、創新、新產品發布、定價和流行病學分析等各種行業因素對市場進行了深入分析。

細分分析

預計微導管細分市場在預測期間（2022-2029 年）將有很高的需求。

由於微導管的進步，預計微導管細分市場將在預測期內快速增長。例如，Covidien plc 的 Apollo Onyx 輸送微導管是美國第一款可拆卸尖端微導管。這種新型微導管旨在解決 Onyx LES 栓塞動靜脈畸形 (bAVM) 中導管取出的技術挑戰。此外，Vascular Perspective Co., Ltd. 的錐形尖端微導管“ASAHI CORSAIR PRO”改善了跟隨性和扭矩傳遞，降低了並發症的可能性，取得了更好的治療效果。此外，基於連接到微流體系統的自組裝聚合物薄膜的電子集成微導管的開發允許以有針對性的方式填充和密封血管缺陷，例如動脈瘤。現在可以輸送液體有效載荷。在預測期內（2022-2029 年），微導管領域的這些進步增加了其在全球市場的主導地位。

區域分析

預計全球神經血管導管市場將由北美主導。

北美將在 2021 年主導全球神經血管導管市場。由於神經血管疾病病例數量的增加和市場上最大的導管回收器，預計在預測期內（2022-2029 年）將保持可觀的市場規模。例如，根據 CDC 的數據，2019 年大約有 223,135 例 TBI 相關住院，2020 年有 64,362 例 TBI 相關死亡，每天有 611 例 TBI 相關住院和 176 例死亡。來自 CDC 的數據不包括在急診科、初級保健、緊急護理和未經治療的 TBI 治療，許多 TBI 患者仍然存在。據腦動脈瘤基金會稱，美國約有 650 萬人患有未破裂的腦動脈瘤。每年每 100,000 人中約有 8 到 10 人破裂。在美國，每年約有 30,000 人患有腦動脈瘤破裂。腦動脈瘤每 18 分鐘破裂一次。此外，Stryker Corporation、Johnson and Johnson、Penumbra Inc. 和 Medtronic Plc 是美國主要的市場參與者，它們確保了北美在全球市場的主導地位並佔據了大部分市場份額。

競爭格局

全球神經血管導管市場的主要參與者有 Stryker、Medtronic、Integer Holdings Corporation、DePuy Synthes（強生公司）、Biomerics、Zeus Industrial Products, Inc.、Imperative Care Inc 和 Penumbra, Inc.。主要參與者採取了各種策略，如產品發布、併購、合作夥伴和聯盟，為全球神經血管導管市場的增長做出貢獻。例如，2022 年 7 月 12 日，美敦力宣布與 CathWorks 達成共同推廣協議，並宣布計劃收購它。此外，2022 年 3 月 1 日，Stryker 收購了 Vocera。

美敦力公司

概述

Medtronic PLC 是一家總部位於愛爾蘭的美國醫療設備製造商。美敦力公司成立於 1949 年，總部位於美國明尼蘇達州明尼阿波利斯市。美敦力經營四項業務：微創治療組、糖尿病組、恢復性治療組和心血管組。

產品組合。

美敦力的神經血管導管產品組合包括 Navien、Phenom、React 抽吸導管、Apollo Onyx 輸送微導管、Echelon 微導管等。

全球神經血管導管市場報告將提供對大約 40 多個市場數據表、45 多個數字和 200 多頁（大約）的訪問。

內容

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 神經血管疾病病例增加
      • 老年人口增加
      • 市場策略
    • 限制因素
      • 缺乏熟練的專業人員
      • 相關並發症
    • 商機
    • 影響分析

第5章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按類型

  • 微導管
  • 氣球導管
  • 接入導管
  • 栓塞導管
  • 其他

第 8 章按材料分類

  • 氟化乙烯丙烯
  • 液晶聚合物
  • 尼龍
  • 聚醚嵌段□胺
  • 聚醚醚酮
  • 其他

第 9 章按應用程序

  • 動脈瘤
  • 神經血管栓塞
  • 椎竇瘺
  • 動脈血管痙攣
  • 其他

第 10 章，最終用戶

  • 醫院
  • 門診手術中心 (ASC)
  • 其他

第 11 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 12 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 產品基準

第 13 章公司簡介

  • 美敦力公司
    • 公司概況
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Stryker
  • Integer Holdings Corporation
  • DePuy Synthes（Johnson and Johnson）
  • Biomerics
  • Zeus Industrial Products, Inc.
  • Imperative Care Inc.
  • Penumbra, Inc.

第14章 DataM

簡介目錄
Product Code: DMMD2103

Market Overview

Neurovascular Catheters Market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 6.7% during the forecast period (2022-2029).

A neurovascular catheter is used to drain or withdraw unwanted fluid from neurovascular organs such as the brain, intracranial spaces, carotid artery, etc. It also administers medications to the neurovascular organs and diagnoses several neurovascular diseases like aneurysms, carotid artery disease, etc.

Market Dynamics

The global neurovascular catheter market is growing due to the prevalence of neurovascular disorders, R&D investments, and technological advancements.

The increasing prevalence of neurovascular disorders and technological advancements propel global market growth.

The increasing cases of neurovascular disorders like ischemic Stroke, stenosis, brain aneurysm, and other illnesses are expected to boost the market. For instance, according to WHO, 1 in 3 people are affected by a neurological disease at some point in their life. Over the past 30 years, the number of deaths due to neurological disorders has increased by almost 40%. As per the World Stroke Organization (WSO), Stroke remains the second-leading cause of death and the third-leading cause of death and disability combined. Also, globally, 70% of strokes and 87% of stroke-related deaths and disability-adjusted life years occur in low- and middle-income countries. Around 15 million people suffer from Stroke worldwide each year. Of these, 5 million die, and another 5 million are permanently disabled. Thus, the increasing number of ischemic stroke cases is driving the market.

The complications and lack of skilled professionals hinder the global neurovascular catheter market growth.

The complications associated with neurovascular catheters are expected to restrain the market. Any procedure that places a catheter inside a blood vessel carries certain risks. They include damage to the blood vessel, bleeding at the puncture site, and infection. FDA stated that it had received a small number of adverse event reports indicating patient injury, and at least one death, associated with the neurovascular guide catheters used in this manner. Also, the use of neurovascular guide catheters for thrombus removal may affect safety and performance, resulting in device failure and other serious adverse effects like perforation, vessel damage, or dissection when used in the most distal regions of the microvasculature.

Industry analysis.

The global neurovascular catheters market report will provide an in-depth analysis of the market based on various industry factors such as porter`s five forces, innovations, new product launches, pricing, epidemiological analysis, Etc.

Segment Analysis

The microcatheter segment is predicted to have a high demand during the forecast period (2022-2029).

The microcatheter segment is expected to grow rapidly over the forecast period, owing to microcatheter advancements. For instance, Covidien plc's Apollo Onyx delivery microcatheter is the first detachable tip microcatheter available in the US. The new microcatheter is designed to solve catheter retrieval's technical challenges during Onyx LES embolizations of arteriovenous brain malformations (bAVMs). Also, ASAHI CORSAIR PRO, a tapered tip microcatheter by Vascular Perspectives Ltd., has increased trackability and torque transmission giving better outcomes with a low probability of complications. Furthermore, the development of Electronically integrated microcatheters based on self-assembling polymer films connected to a microfluidic system allows to deliver of a liquid payload in a targeted manner, e.g., to fill and seal a blood vessel defect, e.g., an aneurysm. These advancements in the microcatheter segment are fueling its dominance over the global market during the forecast period (2022-2029).

Geographical Analysis

North America is predicted to command the global neurovascular catheter market.

North America dominated the global neurovascular catheter market in 2021. It is estimated to hold a significant market size over the forecast period (2022-2029) owing to the increasing cases of neurovascular disorders and maximum catheter retrievers in the market. For instance, as per CDC, in 2019, there were around 223,135 TBI-related hospitalizations and 64,362 deaths in 2020 claimed by TBI, making up 611 hospitalizations and 176 deaths daily as TBI the cause. This data from the CDC excludes the TBI treated in emergency departments, primary care, urgent care or untreated ones leaving behind many TBI patients. According to the Brain Aneurysm Foundation, around 6.5 million United States people have an unruptured brain aneurysm. Annually approximately 8 - 10 per 100,000 people rapture occurs. About 30,000 people in the United States suffer a brain aneurysm rupture each year. A brain aneurysm ruptures every 18 minutes. Furthermore, Stryker Corporation, Johnson and Johnson, Penumbra Inc. and Medtronic Plc are the United States-based key market players holding most of the market share, ensuring the dominance of North America over the global market.

Competitive Landscape

The major global neurovascular catheter market players are Stryker, Medtronic, Integer Holdings Corporation, DePuy Synthes (Johnson and Johnson), Biomerics, Zeus Industrial Products, Inc, Imperative Care Inc, and Penumbra, Inc. The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the neurovascular catheters market globally. For instance, on July 12, 2022, Medtronic announced a co-promotion agreement with CathWorks, with an acquisition plan. Also, on 01-Mar-2022, Stryker acquired Vocera.

Medtronic, Plc.

Overview:

Medtronic plc is Ireland based American medical device company. Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States. Medtronics deals with four different businesses: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group.

Product Portfolio:

The Medtronic, Plc product portfolio for neurovascular catheters contains Navien, Phenom, React Aspiration Catheters, Apollo Onyx delivery microcatheter, Echelon microcatheter, Etc.

The global neurovascular catheters market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Increasing Cases of Neurovascular Disorders
      • 4.1.1.2. Growing Geriatric Population
      • 4.1.1.3. Market Strategies
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of Skilled Professional
      • 4.1.2.2. Associated Complication
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
    • 7.1.2. Market Attractiveness Index, By Type Segment
  • 7.2. Microcatheter
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Balloon catheter
  • 7.4. Access catheters
  • 7.5. Embolization catheters
  • 7.6. Others

8. By Material

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Segment
    • 8.1.2. Market Attractiveness Index, By Material Segment
  • 8.2. Fluorinated Ethylene Propylene
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Liquid Crystal Polymer
  • 8.4. Nylon
  • 8.5. Polyether Block Amide
  • 8.6. Polyether Ether Ketone
  • 8.7. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 9.1.2. Market Attractiveness Index, By Application Segment
  • 9.2. Aneurysms
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Neurovascular Embolic Stroke
  • 9.4. Vertebral And Sinus Fistulas
  • 9.5. Arterial Vasospasm
  • 9.6. Others

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 10.1.2. Market Attractiveness Index, By End User Segment
  • 10.2. Hospitals
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Ambulatory Surgical Centers (ASCs)
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking

13. Company Profiles

  • 13.1. Medtronic, Plc
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Stryker
  • 13.3. Integer Holdings Corporation
  • 13.4. DePuy Synthes (Johnson and Johnson)
  • 13.5. Biomerics
  • 13.6. Zeus Industrial Products, Inc.
  • 13.7. Imperative Care Inc.
  • 13.8. Penumbra, Inc.

LIST NOT EXHAUSTIVE

14. DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us